Boston Partners Purchases Shares of 706,309 Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Boston Partners acquired a significant stake of 706,309 shares in Option Care Health, Inc., worth approximately $24.4 million, during the first quarter.
• Option Care Health reported a quarterly earnings per share of $0.41, surpassing the consensus estimate and showing a 15.4% year-over-year revenue increase.
• Research analysts have a generally positive outlook on the company, with the average price target set at $35.75 and most ratings leaning towards a "buy."

Boston Partners purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 706,309 shares of the company's stock, valued at approximately $24,353,000. Boston Partners owned approximately 0.43% of Option Care Health at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its holdings in Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after purchasing an additional 591,042 shares in the last quarter. Northern Trust Corp raised its position in shares of Option Care Health by 11.8% during the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock valued at $60,934,000 after buying an additional 278,158 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Option Care Health by 4.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company's stock valued at $91,209,000 after buying an additional 99,574 shares during the last quarter. Nuveen LLC bought a new stake in shares of Option Care Health during the first quarter valued at approximately $70,965,000. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Option Care Health by 6,525,926.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock valued at $52,459,000 after buying an additional 1,500,963 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Trading Down 0.4%

Shares of OPCH opened at $28.41 on Friday. The company's fifty day moving average is $30.36 and its 200 day moving average is $31.87. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The stock has a market capitalization of $4.61 billion, a PE ratio of 22.73, a P/E/G ratio of 1.80 and a beta of 0.79. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. The company had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. Option Care Health's quarterly revenue was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.30 earnings per share. Sell-side analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on OPCH shares. Barrington Research reiterated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Finally, JMP Securities lifted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.